Cheng Du Sheng Nuo Biotec Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000051M8
CNY
40.15
-0.1 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
151.07
183.05
116.70
138.31
93.63
102.73
142.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
151.07
183.05
116.70
138.31
93.63
102.73
142.37
Raw Material Cost
68.20
84.50
57.30
62.27
43.83
40.17
52.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.77
3.28
2.95
3.69
2.33
2.94
2.43
Selling and Distribution Expenses
17.49
32.41
36.33
28.12
28.36
32.88
41.68
Other Expenses
0.89
0.09
1.68
0.02
1.18
0.62
0.58
Total Expenditure (Excl Depreciation)
98.35
121.11
113.33
94.25
86.29
82.15
102.40
Operating Profit (PBDIT) excl Other Income
52.699999999999996
61.900000000000006
3.4000000000000004
44.1
7.3
20.6
40
Other Income
1.81
1.63
3.16
0.22
2.87
2.53
5.36
Operating Profit (PBDIT)
62.21
70.16
10.34
54.27
14.17
30.08
52.16
Interest
3.77
3.28
2.95
3.69
2.33
2.94
2.43
Exceptional Items
-0.03
-0.13
0.16
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
82.86
98.55
59.41
76.04
49.80
62.56
89.89
Depreciation
11.23
11.23
9.96
9.96
7.84
7.84
7.50
Profit Before Tax
47.19
55.52
-2.41
40.62
4.00
19.30
42.22
Tax
5.36
8.44
4.57
5.52
-1.27
2.85
3.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
41.84
47.12
-6.92
35.16
5.32
16.47
35.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
41.84
47.12
-6.92
35.16
5.32
16.47
35.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.04
-0.06
-0.06
-0.05
-0.02
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.84
47.08
-6.98
35.10
5.27
16.45
35.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
993.09
966.25
918.34
918.61
882.46
896.43
879.93
Earnings per share (EPS)
0.27
0.3
-0.04
0.22
0.03
0.1
0.23
Diluted Earnings per share
0.27
0.3
-0.04
0.22
0.03
0.1
0.23
Operating Profit Margin (Excl OI)
32.55%
31.31%
-2.38%
31.87%
3.7%
19.18%
27.61%
Gross Profit Margin
38.67%
36.46%
6.47%
36.57%
12.65%
26.42%
34.93%
PAT Margin
27.69%
25.74%
-5.93%
25.42%
5.68%
16.03%
24.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 61.43% vs 2.74% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 688.68% vs -13.11% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 434.51% vs -7.38% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 65.22% vs -4.17% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Cheng Du Sheng Nuo Biotec Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
151.07
0
151.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
151.07
0
151.07
Raw Material Cost
68.20
0
68.20
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.77
0
3.77
Selling and Distribution Expenses
17.49
0
17.49
Other Expenses
0.89
0.00
0.89
Total Expenditure (Excl Depreciation)
98.35
0
98.35
Operating Profit (PBDIT) excl Other Income
52.71
0.00
52.71
Other Income
1.81
0
1.81
Operating Profit (PBDIT)
62.21
0
62.21
Interest
3.77
0
3.77
Exceptional Items
-0.03
0
-0.03
Gross Profit (PBDT)
82.86
0
82.86
Depreciation
11.23
0
11.23
Profit Before Tax
47.19
0
47.19
Tax
5.36
0
5.36
Provisions and contingencies
0
0
0.00
Profit After Tax
41.84
0
41.84
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
41.84
0
41.84
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.84
0
41.84
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
993.09
0
993.09
Earnings per share (EPS)
0.27
0
0.27
Diluted Earnings per share
0.27
0
0.27
Operating Profit Margin (Excl OI)
32.55%
0%
0.00
32.55%
Gross Profit Margin
38.67%
0%
0.00
38.67%
PAT Margin
27.69%
0%
0.00
27.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -17.48% vs 56.90% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 61.43% vs 2.74% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.18 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -11.25% vs 772.86% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 688.68% vs -13.11% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.04 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -11.82% vs 851.39% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 434.51% vs -7.38% in Jun 2024

Quarterly - Interest
Interest 0.38 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.15% vs 10.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 65.22% vs -4.17% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.55%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024